Выбор редакции

Abbott Labs ([[ABT]] -1.4%) has been discussing a federal settlement over former best-selling anti-seizure drug Depakote, which prosecutors allege was being promoted for unapproved uses. Similar settlements recently have run into the many hundreds of millions.

Abbott Labs (ABT -1.4%) has been discussing a federal settlement over former best-selling anti-seizure drug Depakote, which prosecutors allege was being promoted for unapproved uses. Similar settlements recently have run into the many hundreds of millions. Post your comment!
НОВОСТИ ПО ТЕМЕ